Form C - Offering Statement:
SEC Accession No. 0001665160-22-002814
Filing Date
2022-10-26
Accepted
2022-10-26 16:10:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 9646
2 offeringmemoformc.pdf EX-99 60031904
  Complete submission text file 0001665160-22-002814.txt   82685202
Mailing Address 2609 N. DUKE ST. SUITE 300 DURHAM NC 27704
Business Address 2609 N. DUKE ST. SUITE 300 DURHAM NC 27704 919.912.9839
Cytex Therapeutics, Inc. (Filer) CIK: 0001943908 (see all company filings)

EIN.: 205243899 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-31191 | Film No.: 221333357